Prevalence of Candida spp. Isolated from Urine Samples of Pregnant Women from Kassala State, Sudan

Suhndh A. M. Musa^1, , Mamoun Magzoub², Ahmed S. A. Alhassan³ and Nazik Mohamed Abdalla Hammad¹

¹Department of Botany, Faculty of Science, University of Khartoum

²Faculty of Medical Laboratory Science, International University of Africa (IUA) Khartoum, Sudan

³Kassala New Hospital - Kassala, Sudan

Cite this paper:
Suhndh A. M. Musa, Mamoun Magzoub, Ahmed S. A. Alhassan and Nazik Mohamed Abdalla Hammad. Prevalence of Candida spp. Isolated from Urine Samples of Pregnant Women from Kassala State, Sudan. American Journal of Microbiological Research. 2020; 8(3):79-82. doi: 10.12691/ajmr-8-3-1

Abstract

A urinary tract infection (UTI) is a major disease that affects people of all age groups. Women are more susceptible to UTI than men especially pregnancy, mainly due to the different structural features make easy contamination of the UTI with fecal flora. Candida is one of pathogenic which causing this problem. A total of 196 Clean-Catch midstream urine samples were collected from pregnancy referred to Kassala new Hospital and Abdurrahman Elmobark Medical center, their ages between 15 to 40 year old. Grams’ staining, chlamydospores formation and Chromogenic Agar medium used to differentiate between Candida spp. 17 (8.67%) were positive for Candida species, these were C. glabrata (41.18%), C. albicans (23.52%), C. krusei (17.66%), C. dubliniensis (11.76%) and C. tropicalis (5.88%). No co-existence of Candida species was found. In the present study C .glabrata and C. albicans scored the highest frequency of occurrence.

Keywords:
Candida spp UT pregnancy Kassala Sudan

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Azubike, C. N., Nwamadu, O. J., Oji, R. U., and Uzoije, N., “Prevalence of urinary tract infection among school children in a Nigerian rural community”, West African journal of medicine, 13(1), 48-52,‏ 1994.
[2]	Gastmeier, P., Kampf, G., Wischnewski, N. A., Hauer, T., Schulgen, G., Schumacher, M., Daschner F., and Rüden, H., “Prevalence of nosocomial infections in representative German hospitals”, Journal of Hospital infection, 38(1), 37-49, 1998.
[3]	Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., and Pittet, D., “Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis”, The Lancet, 377(9761), 228-241, 2011.
[4]	Gonzalez, C. M., and Schaeffer, A. J., “Treatment of urinary tract infection: what's old, what's new, and what works”, World journal of urology, 17(6), 372-382, 1999.
[5]	Rané, A., and Dasgupta, R., “Urinary tract infection: clinical perspectives on urinary tract infection”, London: springer-verlag, 1(5), 25, 2013.‏
[6]	Haider, G., Zehra, N., Munir, A. A., and Haider, A., “Risk factors of urinary tract infection in pregnancy” JPMA. The Journal of the Pakistan Medical Association, 60(3), 213, 2010.
[7]	Dafnis, E., and Sabatini, S., “The effect of pregnancy on renal function: physiology and pathophysiology”, The American journal of the medical sciences, 303(3), 184-205, 1992.
[8]	Holá, V., Ruzicka, F., and Horka, M., “Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques” FEMS Immunology and Medical Microbiology, 59(3), 525-528, 2010.‏
[9]	Muller, A. E., Oostvogel, P. M., Steegers, E. A., and Joep Dörr, P., “Morbidity related to maternal group B streptococcal infections”, Acta obstetricia et gynecologica Scandinavica, 85(9), 1027-1037, 2006.
[10]	Bacak, S. J., Callaghan, W. M., Dietz, P. M., and Crouse, C., “Pregnancy-associated hospitalizations in the United States, 1999-2000”, American journal of obstetrics and gynecology, 192(2), 592-597‏, 2005.
[11]	Mazor-Dray, E., Levy, A., Schlaeffer, F., and Sheiner, E., “Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?”, The Journal of maternal-fetal and neonatal medicine, 22(2), 124-128, 2009.
[12]	Karlowsky, J. A., Hoban, D. J., DeCorby, M. R., Laing, N. M., and Zhanel, G. G., “Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study”, Antimicrobial agents and chemotherapy, 50(6), 2251-2254.‏ 2006.
[13]	Solberg, O. D., Ajiboye, R. M., and Riley, L. W., “Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli”, Journal of clinical microbiology, 44(4), 1347-1351,‏ 2006.
[14]	Rasti, S., Asadi, M. A., Taghriri, A., Behrashi, M., and Mousavie, G., “Vaginal candidiasis complications on pregnant women”, Jundishapur journal of microbiology, 7(2), 2014.
[15]	Nawrot, U., Wlodarczyk, K., Skala, J., Przondo-Mordarska, A., and Nolard, N., “Evaluation of CandiSelect® 4 (BioRad) a chromogenic medium for yeasts differentiation” MIkologia Lekarska, 12(4), 267, 2005.
[16]	Chelton, E. T. J., and Jones, A. S., “The Gram-Staining Reaction of Disintegrated Micro-organisms652”, Microbiology, 21(3), 652-657, 1959.
[17]	Pollack, J. D., and Benham, R. W., “The chlamydospores of Candida albicans: comparison of three media for their induction”, The Journal of laboratory and clinical medicine, 50(2), 313-317, 1957.
[18]	Walker, L., and Huppert, M., “Corn Meal-Tween Agar: an Improved Medium for the Identification of Candida albicans”, American journal of clinical pathology, 33(2), 190-94, 1960.
[19]	Badri, A., and Mohamed, S., “Clinical Epidemiology and Antibiogram of UTI Patients Attended Different Hospital in Khartoum, Sudan”, Clin Microbiol, 6(301), 2, 2017.
[20]	Weinstein, R. A., Lundstrom, T., and Sobel, J.,” Nosocomial candiduria: a review”, Clinical infectious diseases, 32(11), 1602-1607, 2001.‏
[21]	Manzoor, S., Aziz, M., and Sheikh, A. S., “Identification and Characterization of Candida on CHROMAgar™ in Pregnant Women of Multan”, Pakistan. J Women's Health Care, 7(424), 2167-0420, 2018.
[22]	Kauffman, C. A., Vazquez, J. A., Sobel, J. D., Gallis, H. A., McKinsey, D. S., Karchmer, A. W., ... and Mosher, A., “Prospective multicenter surveillance study of funguria in hospitalized patients”, Clinical Infectious Diseases, 30(1), 14-18, 2000.
[23]	Horvath, L. L., Hospenthal, D. R., Murray, C. K., and Dooley, D. P., “Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida”, Journal of clinical microbiology, 41(6), 2629-2632, 2003.
[24]	Krcmery, V., and Barnes, A. J., “Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance”, Journal of hospital infection, 50(4), 243-260, 2002.
[25]	Falahati, M., Farahyar, S., Akhlaghi, L., Mahmoudi, S., Sabzian, K., Yarahmadi, M., and Aslani, R., “Characterization and identification of candiduria due to Candida species in diabetic patients”, Current medical mycology, 2(3), 10, 2016.
[26]	Weinberger, M., Sweet, S., Leibovici, L., Pitlik, S. D., and Samra, Z., “Correlation between candiduria and departmental antibiotic use”, Journal of Hospital Infection, 53(3), 183-186, 2003.
[27]	Babić, M., and Hukić, M., “Candida albicans and non-albicans species as etiological agent of vaginitis in pregnant and nonpregnant women”, Bosnian journal of basic medical sciences, 10(1), 89, 2010.
[28]	Zarei-Mahmoudabadi, A., Zarrin, M., Ghanatir, F., and Vazirianzadeh, B., “Candiduria in hospitalized patients in teaching hospitals of Ahvaz”, Iranian journal of microbiology, 4(4), 198, 2012.
[29]	Manikandan, C., and Amsath, A., “Characterization and susceptibility pattern of Candida species isolated from urine sample in pattukkottai, Tamilnadu, India”, Int J Pure Appl Zool, 3, 17-23, 2015.
[30]	Khadka, S., Regmi, P., Giri, S., Shah, P. K., and Mishra, S. K., “Identification of Candida species using CHROM agar”, International Journal of Medicine and Biomedical Sciences, 1(3), 10-13, 2016.
[31]	Lagrotteria, D., Rotstein, C., and Lee, C. H., “Treatment of candiduria with micafungin: a case series”, Canadian Journal of Infectious Diseases and Medical Microbiology, 18(2), 149-150, 2007.
[32]	Ghelardi, E., Pichierri, G., Castagna, B., Barnini, S., Tavanti, A., and Campa, M., “Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species”, Clinical microbiology and infection, 14(2), 141-147, 2008.
[33]	Cooke, V. M., Miles, R. J., Price, R. G., Midgley, G., Khamri, W., and Richardson, A. C., “New chromogenic agar medium for the identification of Candida spp.”, Appl. Environ. Microbiol., 68(7), 3622-3627, 2002.
[34]	Metin, D. Y., Pullukçu, H., Polat, S. H., Inci, R., and Tümbay, Z. E., “Do incubation temperature, incubation time, and carbon dioxide affect the chromogenic properties of CHROMagar?”, Turkish Journal of Medical Sciences, 42(6), 977-980, 2012.
[35]	Deorukhkar, S. C., and Shahriar, R., “Identification of Candida Species: Conventional Methods in the Era of Molecular Diagnosis”, Remedy Publications LLC. Annals of Microbiology and Immunology, 1(1), 1002‏, 2018.